Weight gain after liver transplantation and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene

Transplantation

Volumn 79, Issue 10, 2005, Pages 1338-1343

  Toniutto, Pierluigi ^a   Fabris, Carlo ^a   Minisini, Rosalba ^b   Apollonio, Luca ^a   Fumo, Elisabetta ^a   Caldato, Maya ^a   Smirne, Carlo ^b   Pirisi, Mario ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Bone; Clinical transplantation; Complications of clinical transplantation; Immunosuppression (clinical and experimental); Immunosuppressive drugs; Liver; Mechanisms; Metabolic

Indexed keywords

ANGIOTENSIN; CALCINEURIN INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ACE GENE; ADULT; AGED; ALLELE; ARTICLE; BODY MASS; BODY WEIGHT; FEMALE; GENE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WEIGHT GAIN;

ADULT; AGED; ALLELES; BODY MASS INDEX; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POSTOPERATIVE PERIOD; WEIGHT GAIN;

EID: 19544366242     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000158712.42875.51     Document Type: Article

References (33)

1. Everhart JE, Lombardero M, Lake JR, et al. Weight change and obesity after liver transplantation: incidence and risk factors. Liver Transpl Surg 1998; 4(4): 285.
2. Palmer M, Schaffner F, Thung SN. Excessive weight gain after liver transplantation. Transplantation 1991; 51(4): 797.
3. Reuben A. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl 200l; 7(11 Suppl 1): S13.
4. Strazzullo P, Iacone R, Iacoviello L, et al. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann Intern Med 2003; 138(1): 17.
5. Taigen T, De Windt LJ, Lim HW, et al. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2000; 97(3): 1196.
6. Nagata K, Somura F, Obata K, et al. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. Hypertension 2002; 40(2): 168.
7. Expert Panel on the Identification E, and Treatment of Overweight and Obesity in Adults. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998; 158(17): 1855.
8. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20(7): 1183.
9. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289(19): 2560.
10. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359(6396): 641.
11. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20(6): 1433.
12. Eriksson U, Danilczyk U, Penninger JM. Just the beginning: novel functions for angiotensin-converting enzymes. Curr Biol 2002; 12(21): R745.
13. Danser AH, Schunkert H. Renin-angiotensin system gene polymorphisms: potential mechanisms for their association with cardiovascular diseases. Eur J Pharmacol 2000; 410(2-3): 303.
14. Keavney B, McKenzie C, Parish S, et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000; 355(9202): 434.
15. Abbud ZA, Wilson AC, Cosgrove NM, et al. Angiotensin-converting enzyme gene polymorphism in systemic hypertension. Am J Cardiol 1998; 81(2): 244.
16. Daimon M, Oizumi T, Saitoh T, et al. The D allele of the angiotensin-converting enzyme insertion/deletion (1/D) polymorphism is a risk factor for type 2 diabetes in a population-based Japanese sample. Endocr J 2003; 50(4): 393.
17. Uemura K, Nakura J, Kohara K, et al. Association of ACEI/D polymorphism with cardiovascular risk factors. Hum Genet 2000; 107(3): 239.
18. Goossens GH, Blaak EE, van Baak MA. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev 2003; 4(1): 43.
19. Campbell DJ, Habener JF. Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 1987; 121(5): 1616.
20. Shenoy U, Cassis L. Characterization of renin activity in brown adipose tissue. Am J Physiol 1997; 272(3 Pt 1): C989.
21. Crandall DL, Herzlinger HE, Saunders BD, et al. Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res 1994; 35(8): 1378.
22. Cassis LA, Fettinger MJ, Roe AL, et al. Characterization and regulation of angiotensin II receptors in rat adipose tissue. Angiotensin receptors in adipose tissue. Adv Exp Med Biol 1996; 396: 39.
23. Janke J, Engeli S, Gorzelniak K, et al. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 2002; 51(6): 1699.
24. Saint-Marc P, Kozak LP, Ailhaud G, et al. Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology 2001; 142(1): 487.
25. Crandall DL, Armellino DC, Busier DE, et al. Angiotensin II receptors in human preadipocytes: role in cell cycle regulation. Endocrinology 1999; 140(1): 154.
26. Cassis LA, Marshall DE, Fettinger MJ, et al. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol 1998; 274(5 Pt 1):E867.
27. Cassis LA, English VL, Bharadwaj K, et al. Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology 2004; 145(1): 169.
28. Um JY, Mun KS, An NH, et al. Polymorphism of angiotensin-converting enzyme gene and BMI in obese Korean women. Clin Chim Acta 2003; 328(1-2): 173.
29. Crabtree GR. Calcium, calcineurin, and the control of transcription. J Biol Chem 2001; 276(4): 2313.
30. Neal JW, Clipstone NA. Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1 cells. J Biol Chem 2002; 277(51): 49776.
31. Kostis JB, Wilson AC, Hooper WC, et al. Association of angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss. Am Heart J 2002; 144(4): 625.
32. Textor SC, Taler SJ, Canzanello VJ, et al. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl 2000; 6(5): 521.
33. el-Agroudy AE, Wafa EW, Gheith OE, et al. Weight gain after renal transplantation is a risk factor for patient and graft outcome. Transplantation 2004; 77(9): 1381.